Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”

---

In the article titled “MicroRNA-30-3p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21” [1], the authors identified an error introduced during the preparation of the manuscript in Figure 4, where the GAPDH bands were duplicated between Figures 4(d) and 4(h). In Figure 4(d), “ox-LDL + mimics” should also be corrected to “ox-LDL + siRNA.”

Additionally, the significance indicators were omitted from Figures 1, 2, 4, and 5 in error, and in Table 1, a primer was not included. The corrected figures and tables are as below.

Figure 1 

miR-30-5p was down-regulated in patients with atherosclerosis and its functional enrichment analysis. (a) The expression levels of miR-30-5p in patients with atherosclerosis (patients) and normal healthy people (control) were determined by qRT-PCR. indicated p <0.05 vs. control.

(a)

(d)

(g)

Figure 2 

(a)

(d)

(h)

Figure 4 

(a)

(d)

(h)

Figure 5 

Table 1 

Primers’ sequences in the real-time PCR assay.

Due to an error during manuscript preparation, the incorrect miRNA was stated in the title of the manuscript. The article has been updated from “MicroRNA-30-3p” to “MicroRNA-30-5p” as shown above.

The authors apologize for these errors and confirm that they do not impact the conclusions of the article.